4.8 Article

Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis

A. K. Singal et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)

Review Gastroenterology & Hepatology

Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy

Cheng-Yuan Peng et al.

JOURNAL OF HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

George Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2012)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis

Ju Hyun Shim et al.

JOURNAL OF HEPATOLOGY (2010)

Review Gastroenterology & Hepatology

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

George V. Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2010)

Editorial Material Gastroenterology & Hepatology

Chronic Hepatitis B: Update 2009

Anna S. F. Lok et al.

HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

J. J. Y. Sung et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)

Review Gastroenterology & Hepatology

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

Yun-Fan Liaw et al.

HEPATOLOGY INTERNATIONAL (2008)

Review Gastroenterology & Hepatology

Hepatitis B virus-related cirrhosis: Natural history and treatment

CM Chu et al.

SEMINARS IN LIVER DISEASE (2006)

Article Gastroenterology & Hepatology

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

UH Iloeje et al.

GASTROENTEROLOGY (2006)

Article Gastroenterology & Hepatology

Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis

SH Bae et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)

Article Medicine, General & Internal

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea

SH Bae et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2005)

Article Medicine, General & Internal

Lamivudine for patients with chronic hepatitis B and advanced liver disease

YF Liaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Hepatitis B e antigen and the risk of hepatocellular carcinoma

HI Yang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)